Immuneering Corp

Ownership Transactions Reported by 15 Insiders

Symbol
IMRX on Nasdaq
Location
245 Main Street, Second Floor, Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10%+ Owner $8.79M +$55.3K +0.63% Mar 19, 2024
Cormorant Asset Management, LP 10%+ Owner $8.6M -$2.75M -24.3% Apr 1, 2024
Peter Feinberg Director $2.79M +$247K +9.69% Jun 12, 2024
Brett Matthew Hall Chief Scientific Officer $989K +$20K +2.07% Mar 15, 2024
Ann E. Berman Director $144K +$123K +610% Jun 12, 2024
Leah R. Neufeld Chief People Officer $28.9K +$11K +61.5% May 21, 2024
Biren Amin Cfo, Treasurer $23.8K May 12, 2022
Mallory Morales Chief Accounting Officer $20.7K +$4.01K +24.1% Sep 15, 2024
Harold E. Brakewood Chief Business Officer $10K +$10K May 21, 2024
Thomas J. Schall Director $7.39K Jun 12, 2024
Michael Bookman Chief Legal Officer, Secretary $6.24K May 21, 2024
Carpenter Robert J Director Jun 12, 2024
Scott Barrett Chief Medical Officer Feb 15, 2023
Laurie Keating Director Jun 12, 2024
Diana Hausman Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.